Cayratia Carnosa

Cayratia carnosa  (Wall.) Gagnep.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym C. trifolia (L.) Domin. Vitis carnosa Wall. V.trifolia Linn.
Family Vitaceae.
Habitat Throughout the warmer parts of India, from Jammu and Rajasthan to Assam and up to 300 m.
Ayurvedic Gandira.
Siddha / Tamil Tumans.
Action Leaves, seeds, roots— astringent, applied to ulcers and boils. Leaves—diaphoretic (recommended in high fever). Rootgiven in anaemic conditions. Aerial parts—CNS active, hypothermic. The stems, leaves and roots contain hydrocyanic acid. Presence of delphinidin and cyanidin is reported in the leaves.
Taxonomic Cohort Genus Cayratia (2 documented species); Family Vitaceae (10 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Cayratia carnosa (taxonomically cited with authority (Wall.) Gagnep.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Vitaceae (primary family classification: Vitaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. trifolia (L.) Domin. Vitis carnosa Wall. V.trifolia Linn, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout the warmer parts of India, from Jammu and Rajasthan to Assam and up to 300 m.

Across classical and vernacular Indian systems of medicine, Cayratia carnosa is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Gandira; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Tumans. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cayratia carnosa are: Leaves, seeds, roots— astringent, applied to ulcers and boils. Leaves—diaphoretic (recommended in high fever). Rootgiven in anaemic conditions. Aerial parts—CNS active, hypothermic. The stems, leaves and roots contain hydrocyanic acid. Presence of delphinidin and cyanidin is reported in the leaves. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

The therapeutic activity of Cayratia carnosa is grounded in its documented pharmacological actions (Leaves, seeds, roots— astringent, applied to ulcers and boils. Leaves—diaphoretic (recommended in high fever). Rootgiven in anaemic conditions. Aerial parts—CNS active, hypothermic. The stems, leaves and roots contain hydrocyanic acid. Presence of delphinidin and cyanidin is reported in the leaves) and the characteristic secondary metabolite profile of the family Vitaceae.

4. Comparative Genus & Family Pharmacognosy

Taxonomically, the genus Cayratia comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Cayratia pedata (Action: Leaves—astringent and refrigerant (used for ulcers, diarrhoea, uterine and other…). Comparing Cayratia carnosa alongside its congeners in genus Cayratia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.

At the family level, Vitaceae encompasses 10 documented medicinal species (0.55% of the 1,814-species flora). Other representative medicinal members of Vitaceae include: Cayratia pedata (Godhaapadi), Cissus quadrangula (Asthisamhaara), Leea aequata (Kaakajanghaa), Leea crispa (Banachelt), Parthenocissus himalayana (Kandur). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image1

Figure 1: Quantitative documentation profile across all 10 medicinal species of family Vitaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

In clinical and traditional dispensing, preparation and administration of Cayratia carnosa follow the plant-part modalities specified under its therapeutic action (Leaves, seeds, roots— astringent, applied to ulcers and boils. Leaves—diaphoretic (recommended in high fever). Rootgiven in anaemic conditions. Aerial parts—CNS active, hypothermic. The stems, leaves and roots contain hydrocyanic acid. Presence of delphinidin and cyanidin is reported in the leaves), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Cayratia carnosa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top